Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside presented as an ophthalmic solution for ocular use. It is employed to treat bacterial eye infections such as conjunctivitis and keratitis in adults and children. GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Netilmicin is an aminoglycoside antibiotic used for bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and speeds symptom resolution. - Bacterial keratitis (corneal ulcer): eradicates causative organisms and promotes corneal healing. - Post‑operative ocular infection: prevents or treats infection following eye surgery.

Netilmicin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging sensation upon instillation. - Redness of the conjunctiva. - Tearing or increased lacrimation. - Blurred vision temporarily after use. - Foreign body sensation. - Mild ocular irritation.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Allergic reactions such as eyelid edema or rash. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic ototoxicity (rare with ocular use). - Nephrotoxicity (rare, usually with systemic exposure). - Severe hypersensitivity anaphylaxis.

When using Netenax, consider the following safety measures. - Pregnancy: Use only if clearly needed; safety data are limited. - Breastfeeding: Caution advised; potential secretion in milk is unknown. - Renal impairment: Monitor renal function if systemic absorption is possible. - Concomitant ototoxic drugs: Avoid or use with caution to reduce risk of systemic toxicity. - Contact lens wearers: Remove lenses before instillation and wait before reinserting. Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Netilmicin may interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use can increase nephro‑ and ototoxic risk. - Loop diuretics (e.g., furosemide): may potentiate renal toxicity. - Neuromuscular blocking agents: risk of enhanced blockade.

Moderate Interactions (Monitor Closely): - Topical ophthalmic agents containing preservatives: may increase ocular irritation. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive corneal effects. - Other topical antibiotics: assess for antagonistic activity or resistance development.